Protease inhibitors, compositions and methods of use
AssigneesUniversity of Florida Research Foundation, Inc., Smithsonian Institution
InventorsHendrik Luesch, Valerie J. Paul, Jason C. Kwan
Life of this patent
Estimating the term…
Abstract
This invention relates to grassystatins A, B and C, and their isolated or purified forms. The compounds of the invention are useful as aspartic protease, gamma secretase, or metalloprotease inhibitors. Methods of using the compounds and compositions thereof are also disclosed.
Claims7
An isolated compound selected from the group of grassystatins A, B and C as follows:
- or a pharmaceutically acceptable salt, ester, amide, hydrate, stereoisomer, or solvate thereof.
A pharmaceutical composition comprising a compound selected from the group of grassystatins A, B and C, or a pharmaceutically acceptable salt, ester, amide, hydrate, stereoisomer, or solvate thereof, together with a pharmaceutically acceptable carrier or diluent.
A method of treating a disease or disorder in a subject, the method comprising administering to the subject an effective amount of a compound selected from the group of grassystatins A, B and C, or a pharmaceutically acceptable salt, ester, hydrate, or solvate thereof, wherein the disease or disorder is selected from the group consisting of disorders of the cell cycle, neurodegenerative disorders, cancer, and Alzheimer's disease.
A method of inhibiting T-cell proliferation in a subject, the method comprising administering to the subject an effective amount of a compound selected from the group of grassystatins A and B, or a pharmaceutically acceptable salt, ester, hydrate, or solvate thereof.
A method of treating a disease or disorder in a subject, the method comprising administering to the subject an effective amount of a compound selected from the group of grassystatins A and B, or a pharmaceutically acceptable salt, ester, hydrate, or solvate thereof, wherein the disease or disorder is selected from the group consisting of infection, autoimmune disorders, allergic diseases, and transplant rejection.
Dependencies are inferred from the claim text.